Skip to main content
Top
Published in: Journal of General Internal Medicine 2/2019

01-02-2019 | Editorial

Breast Density Legislation and the Promise Not Attained

Author: Jennifer S. Haas, MD, MSc

Published in: Journal of General Internal Medicine | Issue 2/2019

Login to get access

Excerpt

Strong patient advocacy has resulted in widespread adoption of state legislation that requires notification of a finding of dense breast tissue on mammography. Approximately 40% of US women have dense breast tissue and could potentially receive legislatively mandated reporting about the role of breast density on “masking,” breast cancer risk, and the option for supplemental screening with ultrasound or magnetic resonance imaging (MRI).1 Despite the well-intentioned goal of improving informed decision making, the impact of breast density legislation on understanding of breast cancer risk, awareness of the limitations of mammography as a screening test, or the timely diagnosis of breast cancer has largely not been demonstrated.25
Literature
1.
go back to reference Sprague BL, Gangnon RE, Burt V, et al. Prevalence of mammographically dense breasts in the United States. J Natl Cancer Inst 2014;106. Sprague BL, Gangnon RE, Burt V, et al. Prevalence of mammographically dense breasts in the United States. J Natl Cancer Inst 2014;106.
2.
go back to reference Rhodes DJ, Radecki Breitkopf C, Ziegenfuss JY, Jenkins SM, Vachon CM. Awareness of breast density and its impact on breast cancer detection and risk. J Clin Oncol : Off J Am Soc Clin Oncol 2015;33:1143–50.CrossRef Rhodes DJ, Radecki Breitkopf C, Ziegenfuss JY, Jenkins SM, Vachon CM. Awareness of breast density and its impact on breast cancer detection and risk. J Clin Oncol : Off J Am Soc Clin Oncol 2015;33:1143–50.CrossRef
3.
go back to reference Miles RC, Lehman C, Warner E, Tuttle A, Saksena M. Patient-reported breast density awareness and knowledge after breast density legislation passage. Acad Radiol 2018. Miles RC, Lehman C, Warner E, Tuttle A, Saksena M. Patient-reported breast density awareness and knowledge after breast density legislation passage. Acad Radiol 2018.
4.
go back to reference Houssami N, Lee CI. The impact of legislation mandating breast density notification - review of the evidence. Breast 2018;42:102–12.CrossRefPubMed Houssami N, Lee CI. The impact of legislation mandating breast density notification - review of the evidence. Breast 2018;42:102–12.CrossRefPubMed
5.
go back to reference Richman I, Asch SM, Bendavid E, Bhattacharya J, Owens DK. Breast density notification legislation and breast cancer stage at diagnosis: early evidence from the SEER registry. J Gen Intern Med 2017;32:603–9.CrossRefPubMed Richman I, Asch SM, Bendavid E, Bhattacharya J, Owens DK. Breast density notification legislation and breast cancer stage at diagnosis: early evidence from the SEER registry. J Gen Intern Med 2017;32:603–9.CrossRefPubMed
6.
go back to reference Kressin NR, Gunn CM, Battaglia TA. Content, readability, and understandability of dense breast notifications by state. Jama 2016;315:1786–8.CrossRefPubMed Kressin NR, Gunn CM, Battaglia TA. Content, readability, and understandability of dense breast notifications by state. Jama 2016;315:1786–8.CrossRefPubMed
8.
go back to reference Klinger EV, Kaplan CP, St Hubert S, Birdwell RL, Haas JS. Patient and provider perspectives on mammographic breast density notification legislation. MDM Policy Pract 2016;1:2381468316680620.PubMedCentralPubMed Klinger EV, Kaplan CP, St Hubert S, Birdwell RL, Haas JS. Patient and provider perspectives on mammographic breast density notification legislation. MDM Policy Pract 2016;1:2381468316680620.PubMedCentralPubMed
9.
go back to reference Haas JS, Giess CS, Harris KA, Ansolabehere J, Kaplan CP. Randomized trial of personalized breast density and breast cancer risk notification. J Gen Intern Med 2018. Haas JS, Giess CS, Harris KA, Ansolabehere J, Kaplan CP. Randomized trial of personalized breast density and breast cancer risk notification. J Gen Intern Med 2018.
10.
go back to reference Tice JA, Miglioretti DL, Li CS, Vachon CM, Gard CC, Kerlikowske K. Breast density and benign breast disease: risk assessment to identify women at high risk of breast cancer. J Clin Oncol 2015;33:3137–43.CrossRefPubMedCentralPubMed Tice JA, Miglioretti DL, Li CS, Vachon CM, Gard CC, Kerlikowske K. Breast density and benign breast disease: risk assessment to identify women at high risk of breast cancer. J Clin Oncol 2015;33:3137–43.CrossRefPubMedCentralPubMed
11.
go back to reference Sprague BL, Conant EF, Onega T, et al. Variation in mammographic breast density assessments among radiologists in clinical practice: a multicenter observational study. Ann Intern Med 2016;165:457–64.CrossRefPubMedCentralPubMed Sprague BL, Conant EF, Onega T, et al. Variation in mammographic breast density assessments among radiologists in clinical practice: a multicenter observational study. Ann Intern Med 2016;165:457–64.CrossRefPubMedCentralPubMed
Metadata
Title
Breast Density Legislation and the Promise Not Attained
Author
Jennifer S. Haas, MD, MSc
Publication date
01-02-2019
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 2/2019
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-018-4754-6

Other articles of this Issue 2/2019

Journal of General Internal Medicine 2/2019 Go to the issue

Healing Arts: Materia Medica

What I Would Do

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.